Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lifang Huang

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Wounds : a Compendium of Clinical Research and Practice|November 2, 2025
Closure rate of chronic wound with sinus tract based on morphological and pathological features of the endoscopic evaluated classificationXian Ma, Yakupu Aobuliaximu, Di Zhang, et al.
Human Vaccines & Immunotherapeutics|April 15, 2024
Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in ChinaAodi Huang, Xia Xu, Lin Tang, et al.
Scientific Reports|June 21, 2022
The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activityShangkun Zhang, Chaojiang Gu, Lifang Huang, et al.
The Journal of Allergy and Clinical Immunology|May 30, 2020
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trialYang Cao, Jia Wei, Liang Zou, et al.
The New England Journal of Medicine|January 14, 2026
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic AnemiaRuonan Li, Hong Pan, Lele Zhang, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Wounds : a Compendium of Clinical Research and Practice|November 2, 2025
Closure rate of chronic wound with sinus tract based on morphological and pathological features of the endoscopic evaluated classificationXian Ma, Yakupu Aobuliaximu, Di Zhang, et al.
Human Vaccines & Immunotherapeutics|April 15, 2024
Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in ChinaAodi Huang, Xia Xu, Lin Tang, et al.
Scientific Reports|June 21, 2022
The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activityShangkun Zhang, Chaojiang Gu, Lifang Huang, et al.
The Journal of Allergy and Clinical Immunology|May 30, 2020
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trialYang Cao, Jia Wei, Liang Zou, et al.
The New England Journal of Medicine|January 14, 2026
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic AnemiaRuonan Li, Hong Pan, Lele Zhang, et al.
Pageof 12